MeiraGTx Holdings plc MGTX Debt-to-equity

Debt-to-equity at other companies

Regeneron PharmaceuticalsREGN

0.1×0.0×

Opus GeneticsIRD

0.1×—

RegenxbioRGNX

1×+0.6×

Relay Therapeutics, Inc.RLAY

0×0.0×

Prime MedicinePRME

2.8×+0.9×

4D Molecular TherapeuticsFDMT

0×0.0×

FAQ

What is MeiraGTx Holdings plc's debt-to-equity?

MeiraGTx Holdings plc (MGTX) reported debt-to-equity of 27.2× in Q2 2025.

How has MeiraGTx Holdings plc's debt-to-equity changed year-over-year?

MeiraGTx Holdings plc's debt-to-equity increased by 2385.0% year-over-year, from 1.1× to 27.2×.

What is the long-term trend for MeiraGTx Holdings plc's debt-to-equity?

Over 4 years (2020 to 2024), MeiraGTx Holdings plc's debt-to-equity has grown at a 91.3% compound annual growth rate (CAGR), from 0.1× to 1.3×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.